Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

6.76
Delayed Data
As of May 25
 -0.0647 / -0.95%
Today’s Change
5.60
Today|||52-Week Range
11.40
-10.41%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close6.82
Today’s open6.92
Day’s range6.70 - 6.92
Volume8,312
Average volume (3 months)11,296
Market cap$28.5M
Dividend yield--
Data as of 3:19pm ET, 05/25/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+34.64%
P/E ratio19.2
Price/Sales2.32
Price/Book1.96

Competitors

 Today’s
change
Today’s
% change
ORPNBio Blast Pharma Ltd+0.13+7.20%
KDUSCadus Corp0.000.00%
DRIOLabstyle Innovations...+0.12+2.45%
HSGXHistogenics Corp-0.06-3.02%
Data as of 3:54pm ET, 05/25/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$10.2M
Annual profit (last year)$1.2M
Net profit margin11.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts

Partner Offers

Search for Jobs